Home » Avastin Touted Over Long Term for NSCLC
Avastin Touted Over Long Term for NSCLC
Carefully selected patients with non-small cell lung cancer (NSCLC) achieved a median overall survival of 31 months with first-line chemotherapy with bevacizumab, followed by long-term bevacizumab maintenance.
MedPage Today
MedPage Today
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May